Table of Contents
Chapter 1. Global Arthritic Therapeutic Market Executive Summary
1.1. Global Arthritic Therapeutic Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Arthritic Therapeutic Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Arthritic Therapeutic Market Dynamics
3.1. Market Drivers
3.1.1. Growing Prevalence of Arthritis Conditions
3.1.2. Aging Population and Lifestyle Factors
3.1.3. Enhanced Healthcare Infrastructure
3.2. Market Challenges
3.2.1. Availability of Alternative and Complementary Therapies
3.2.2. Insufficient Diagnosis
3.3. Market Opportunities
3.3.1. Focus on Biosimilar Research and Development
3.3.2. Personalized Medicine and Cost-effective Healthcare Solutions
3.3.3. Technological Advancements in Therapeutic Solutions
Chapter 4. Global Arthritic Therapeutic Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Arthritic Therapeutic Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Arthritic Therapeutic Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.2.2. Disease Modified Anti-rheumatoid Drugs (DMARDs)
5.2.3. Biologics
5.2.4. Others
Chapter 6. Global Arthritic Therapeutic Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Arthritic Therapeutic Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Rheumatoid Arthritis
6.2.2. Osteoarthritis
6.2.3. Psoriatic Arthritis
6.2.4. Ankylosing Spondylitis
6.2.5. Others
Chapter 7. Global Arthritic Therapeutic Market Size & Forecasts by Region 2022-2032
7.1. North America Arthritic Therapeutic Market
7.1.1. U.S. Arthritic Therapeutic Market
7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Arthritic Therapeutic Market
7.1.3. Mexico Arthritic Therapeutic Market
7.2. Europe Arthritic Therapeutic Market
7.2.1. U.K. Arthritic Therapeutic Market
7.2.2. Germany Arthritic Therapeutic Market
7.2.3. France Arthritic Therapeutic Market
7.2.4. Italy Arthritic Therapeutic Market
7.2.5. Spain Arthritic Therapeutic Market
7.2.6. Rest of Europe Arthritic Therapeutic Market
7.3. Asia-Pacific Arthritic Therapeutic Market
7.3.1. China Arthritic Therapeutic Market
7.3.2. Japan Arthritic Therapeutic Market
7.3.3. India Arthritic Therapeutic Market
7.3.4. Australia Arthritic Therapeutic Market
7.3.5. South Korea Arthritic Therapeutic Market
7.3.6. Rest of Asia Pacific Arthritic Therapeutic Market
7.4. Latin America Arthritic Therapeutic Market
7.4.1. Brazil Arthritic Therapeutic Market
7.4.2. Colombia Arthritic Therapeutic Market
7.4.3. Argentina Arthritic Therapeutic Market
7.4.4. Rest of Latin America Arthritic Therapeutic Market
7.5. Middle East & Africa Arthritic Therapeutic Market
7.5.1. Saudi Arabia Arthritic Therapeutic Market
7.5.2. South Africa Arthritic Therapeutic Market
7.5.3. North Africa Arthritic Therapeutic Market
7.5.4. Rest of MEA Arthritic Therapeutic Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Viatris Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Novartis AG
8.3.3. LEO Pharma
8.3.4. Bausch Health (Storz Ophthalmic Instrument)
8.3.5. Johnson & Johnson
8.3.6. Merck & Co., Inc.
8.3.7. AbbVie Inc.
8.3.8. Pfizer Inc.
8.3.9. Amgen Inc.
8.3.10. Celltrion Inc.
8.3.11. Roche Holding AG
8.3.12. Eli Lilly and Company
8.3.13. UCB S.A.
8.3.14. Bristol-Myers Squibb Company
8.3.15. Sanofi
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes